Anavex Life Sciences | 10-K: Annual report
Anavex Stock Rallies 30% on Business Updates
Anavex Life Sciences Up Over 29%, on Pace for Largest Percent Increase Since December 2022 -- Data Talk
Earnings Call Summary | Anavex Life Sciences(AVXL.US) Q4 2024 Earnings Conference
Honda Motor, Rumble, Despegar.com And Other Big Stocks Moving Higher On Monday
D. Boral Capital Maintains Buy on Anavex Life Sciences, Maintains $46 Price Target
Anavex Life Sciences Analyst Ratings
Anavex Life Sciences' Loss Widens on Higher Costs
Anavex Life Sciences Anticipates a Current Cash Utilization Rate Runway of Around Four Years>AVXL
Anavex Life Sciences: Cash and Cash Equivalents of $132.2M at Sept 30 >AVXL
Anavex Life Sciences Q4 2024 GAAP EPS $(0.14) Beats $(0.16) Estimate; Cash Of $132.2M
Press Release: Anavex Life Sciences Reports Fiscal 2024 Fourth Quarter Financial Results and Provides Business Update
Anavex Life Sciences 4Q Loss/Shr 14c >AVXL
Anavex's Alzheimer's Drug Blarcamesine Accepted for Review by European Regulators
Blarcamesine Receives EMA Filing Acceptance for Treatment of Alzheimer's Disease
Express News | Blarcamesine Receives EMA Filing Acceptance for Treatment of Alzheimer’s Disease
Dow Jumps Around 500 Points But Records 3rd Straight Weekly Loss: Greed Index Moves To 'Fear' Zone
Qualcomm, Limoneira And 3 Stocks To Watch Heading Into Monday
Earnings Scheduled For December 23, 2024
Here Are the Major Earnings Before the Open Tomorrow